BioAge Labs Inc.

3.83
-0.05 (-1.29%)
At close: Mar 28, 2025, 3:59 PM
3.92
2.35%
After-hours: Mar 28, 2025, 07:50 PM EDT

BioAge Labs Cash Flow Statement

Year FY24 FY23 FY22
Net Income -71.11M -63.85M -39.72M
Depreciation & Amortization 167K 162K 129K
Stock-Based Compensation 6.98M 3.02M 2.54M
Other Working Capital 11.17M 7.1M -199K
Other Non-Cash Items 1.26M 16.6M 77K
Deferred Income Tax n/a n/a n/a
Change in Working Capital 11.18M 6.71M 795K
Operating Cash Flow -51.52M -37.36M -36.18M
Capital Expenditures -366K -166K -103K
Acquisitions n/a n/a n/a
Purchase of Investments n/a -100K n/a
Sales Maturities Of Investments n/a n/a n/a
Other Investing Acitivies n/a n/a n/a
Investing Cash Flow -366K -266K -103K
Debt Repayment -6M 35M 2.5M
Common Stock Repurchased n/a n/a n/a
Dividend Paid n/a n/a n/a
Other Financial Acitivies 165.58M -59K -1K
Financial Cash Flow 381.2M 34.94M 2.5M
Net Cash Flow 329.39M -2.69M -33.54M
Free Cash Flow -51.89M -37.53M -36.28M